In addition to this novel finding, the differentially expressed genes were also enriched in TNF signaling, cytokine interactions, microRNAs in cancer, p53 signaling pathways and other cellular processes (Fig. 1I), which were consistent with the previous reports on KRAS regulation of gene expression (24, 25, 26, 27). The gene discussed is TP53; the disease is cancer.